Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | 0.0031 | 0.011 | 0.0003 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0109 | 0.0109 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.004 | 0.0181 | 0.0275 |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0362 | 0.2714 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0134 | 0.0918 | 0.0918 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.1286 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0205 | 0.0087 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0362 | 0.2714 | 1 |
Brugia malayi | maoC like domain containing protein | 0.008 | 0.0492 | 0.0492 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.1285 | 0.1285 |
Mycobacterium ulcerans | hypothetical protein | 0.0031 | 0.011 | 0.0003 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0205 | 0.0087 |
Mycobacterium ulcerans | hypothetical protein | 0.0031 | 0.011 | 0.0003 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0205 | 0.0087 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0362 | 0.2714 | 0.5 |
Loa Loa (eye worm) | oxidoreductase | 0.0034 | 0.0134 | 0.0134 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0119 | 0.0119 |
Toxoplasma gondii | sterol carrier protein-2 HAD-2SCP-2 | 0.0072 | 0.0427 | 0.0741 |
Loa Loa (eye worm) | hypothetical protein | 0.1286 | 1 | 1 |
Mycobacterium tuberculosis | Probable 3-hydroxyacyl-thioester dehydratase HtdY | 0.008 | 0.0492 | 0.1467 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.004 | 0.0181 | 0.0181 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.03 | 0.03 |
Mycobacterium ulcerans | hypothetical protein | 0.0031 | 0.011 | 0.0003 |
Entamoeba histolytica | hypothetical protein | 0.0362 | 0.2714 | 1 |
Onchocerca volvulus | 0.0055 | 0.03 | 0.0183 | |
Mycobacterium ulcerans | hypothetical protein | 0.008 | 0.0492 | 0.147 |
Mycobacterium ulcerans | dehydratase | 0.008 | 0.0492 | 0.147 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0362 | 0.2714 | 1 |
Mycobacterium ulcerans | phosphopantetheinyl transferase, PptII | 0.0362 | 0.2714 | 1 |
Mycobacterium ulcerans | (3R)-hydroxyacyl-ACP dehydratase subunit HadC | 0.0031 | 0.011 | 0.0003 |
Loa Loa (eye worm) | short chain dehydrogenase/reductase family oxidoreductase | 0.004 | 0.0181 | 0.0181 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.004 | 0.0181 | 0.0275 |
Echinococcus multilocularis | tumor protein p63 | 0.0379 | 0.285 | 0.2764 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0119 | 0.0119 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0034 | 0.0134 | 0.0134 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.1286 | 1 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0119 | 0.0119 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0362 | 0.2714 | 0.5 |
Echinococcus granulosus | tumor protein p63 | 0.0379 | 0.285 | 0.2764 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0362 | 0.2714 | 0.5 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0362 | 0.2714 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0134 | 0.0918 | 0.0918 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.1285 | 0.118 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0119 | 0.0119 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.1285 | 0.118 |
Mycobacterium ulcerans | (3R)-hydroxyacyl-ACP dehydratase subunit HadA | 0.0031 | 0.011 | 0.0003 |
Mycobacterium leprae | conserved hypothetical protein | 0.0362 | 0.2714 | 1 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.1286 | 1 | 1 |
Brugia malayi | sterol carrier protein | 0.0031 | 0.0109 | 0.0109 |
Loa Loa (eye worm) | SCP-2 sterol transfer family protein | 0.0031 | 0.0109 | 0.0109 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0055 | 0.03 | 0.0183 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0119 | 0.0119 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0362 | 0.2714 | 0.5 |
Mycobacterium ulcerans | 4'-phosphopantetheinyl transferase | 0.0362 | 0.2714 | 1 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.1285 | 0.1285 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0205 | 0.0205 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.004 | 0.0181 | 0.0272 |
Brugia malayi | MH2 domain containing protein | 0.0134 | 0.0918 | 0.0918 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0115 | 0.0115 |
Onchocerca volvulus | 0.0034 | 0.0134 | 0.0015 | |
Brugia malayi | SCP-2 sterol transfer family protein | 0.0031 | 0.0109 | 0.0109 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.1285 | 0.118 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.1285 | 0.1285 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0205 | 0.0087 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0362 | 0.2714 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.0492 | 0.0492 |
Onchocerca volvulus | 0.1286 | 1 | 1 | |
Mycobacterium tuberculosis | Probable dehydrogenase. Possible 2-enoyl acyl-CoA hydratase. | 0.008 | 0.0492 | 0.1467 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0362 | 0.2714 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.631 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 7.3078 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (binding) | 11.2202 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.